Neuroscientists are developing drugs to help improve cognition among people with dementia and Alzheimer’s, but increasingly these drugs and other cognitive enhancers are being taken by healthy individuals keen to improve their performance. Barbara Sahakian, Professor of Clinical Neuropsychology, believes it’s time for an open debate about the ethical issues surrounding the use of new types of drugs which could in the future be used to make us all clever, well-behaved and sociable.
Listen now (45minutes)to BBC Radio 4’s Start the Week Andrew Marr talks to 4 leading scientists , and which includes a discussion of the ethics of cognitive enhancers
